# Bendamustine and Idarubicin in Treating Older Patients With Previously Untreated AML or MDS

> **NCT01141725** · PHASE1,PHASE2 · COMPLETED · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 39 (actual)

## Conditions studied

- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- Adult Acute Myeloid Leukemia With Del(5q)
- Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
- Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)
- Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)
- Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)
- de Novo Myelodysplastic Syndromes
- Myelodysplastic Syndrome With Isolated Del(5q)
- Untreated Adult Acute Myeloid Leukemia

## Interventions

- **DRUG:** bendamustine hydrochloride
- **DRUG:** idarubicin

## Key facts

- **NCT ID:** NCT01141725
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2017-08-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01141725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01141725, "Bendamustine and Idarubicin in Treating Older Patients With Previously Untreated AML or MDS". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT01141725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*